New Delhi: The Union Health Ministry reached an arrangement with Hyderabad-based vaccine manufacturer Biological-E to reserve nearly 30 crore coronavirus vaccine jabs for which it will be making an advance payment of Rs 1500 crore.
The above-mentioned Covid vaccine doses will be manufactured and stockpiled by Biological-E themselves from August to December this year, a ministry statement confirmed on Thursday.
The coronavirus vaccine of Biological-E is presently undergoing phase-3 clinical trial after showing optimism outputs during phase 1 and 2 trials.
The vaccine is being manufactured by Biological-E is a RBD protein sub-unit vaccine and will reportedly be available in the next few months.
“The proposal of Biological-E was scrutinised and then recommended for approval after due diligence by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC),” the statement said.
Centre’s arrangement with Biological-E is part of the wider endeavour of the Indian government to encourage indigenous Covid vaccine manufacturers by providing backing in research and development and also financial support, it also said.
The Department of Biotechnology has provided financial assistance in terms of grant-in-aid of over Rs 100 crore and also partnered with Biological-E to perform all animal challenge and assay studies through Faridabad’s Research Institute Translational Health Science Technology Institute (THSTI.
This entire initiative has been undertaken as part of Centre’s ‘Mission COVID Suraksha, the Indian COVID-19 Vaccine Development Mission,’ which was launched to accelerate and reinforce coronavirus vaccine development efforts as part of the third stimulus package, Atmanirbhar 3.0, the statement said.
India’s COVID-19 Vaccine Tally
India on Thursday (June 3) crossed the 22 crore figure in vaccination doses across the country according to the date of the Union Ministry of Health and Family Welfare. A total of 22,10,43,693 vaccine doses have been administered till 7 am on June 3. Out the this, 24,26,265 doses were given on June 2 alone.
The liberalised and accelerated phase-3 strategy of COVID-19 vaccination has come into force from May 1, 2021 after which everyone above the age of 18 was eligible to receive a vaccine shot.